Skip to content

Clinical trials

Phase 3 Stroke trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: Belgium Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20053
20061
20082
20092
20102
20111
20122
20133
20142
20161
20183
20191
20211
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated6
Active, not recruiting2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
AstraZeneca3
Bayer3
Boehringer Ingelheim3
Pfizer2
CSL Behring1
Cliniques universitaires Saint-Luc- Université Catholique de Louvain1
CoAxia1
Daiichi Sankyo1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke29
Myocardial Infarction11
Cardiovascular Diseases9
Atrial Fibrillation5
Ischemic Attack, Transient5
Heart Diseases4
Ischemic Stroke4
Acute Coronary Syndrome3
Coronary Artery Disease3
Hyperlipidemias3

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.